{"id":"W4414041618","doi":"10.1055/s-0045-1810977","title":"Outcomes by transarterial chemoembolization (TACE) modality from participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D)+bevacizumab (B)+TACE and placebos (PBO)+TACE: EMERALD-1 subgroup analysis","year":2025,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Subgroup analysis; Hepatocellular carcinoma; Modality (human–computer interaction); Hepatocellular cancer; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001181704,0.001010152,0.002847439,0.0006108144,0.000225003,0.0007493543,0.0004924494,0.0009001078,0.002210422],"category_scores_gemma":[0.002095674,0.0004632439,0.0101163,0.0007801809,0.0002292414,0.0005318816,0.0007847408,0.001476436,0.0002286926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006014999,"about_ca_system_score_gemma":0.0007899856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003531408,"about_ca_topic_score_gemma":0.006654719,"domain_scores_codex":[0.9988134,0.0003184009,0.0002692155,0.0002792774,0.0001283954,0.0001913449],"domain_scores_gemma":[0.9995081,0.0001770377,0.0001480587,0.00006922947,0.00004282528,0.00005475587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4869294,0.0008874612,0.1727276,0.01458842,0.2441608,0.0006977312,0.0005981572,0.002563761,0.007375413,0.0005242892,0.008556763,0.06039024],"study_design_scores_gemma":[0.1357762,0.03342012,0.4859167,0.00168119,0.3167147,0.001068511,0.001233471,0.004432033,0.003331359,0.003084114,0.01306197,0.0002796121],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9576024,0.02826512,0.001226849,0.0004093349,0.0004648925,0.0007729294,0.009304003,0.00004984509,0.001904662],"genre_scores_gemma":[0.9912096,0.003054758,0.0002788345,0.0003479398,0.0001503186,0.0008117052,0.002915606,0.00001409929,0.001217032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003531408,"threshold_uncertainty_score":0.007394552,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02510027255390688,"score_gpt":0.2678743095935712,"score_spread":0.2427740370396643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}